Ashvattha Therapeutics

0 followers

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Industries

Employees

11-50

Links


Org chart

Jeffrey L. Cleland
Chairman, President & CEO
Collapse
S. Sakura Minami
VP Translational Medicine And Nonclinical Development

Board & advisors

Kannan Rangaramanujam
Co-Founder & Chair, Scientific Advisory Board
George Montgomery
Executive Chairman
Jay Zaveri
Board Director
Nicholas A. Peppas
Scientific Advisor
Hamid Ghandehari
Scientific Advisor
Kim Green
Scientific Advisor
Samir Mitragotri
Scientific Advisor
G. Mani Subramanian
Scientific Advisor